scholarly journals The trigger (and the restriction) of Torso RTK activation

Open Biology ◽  
2018 ◽  
Vol 8 (12) ◽  
pp. 180180 ◽  
Author(s):  
Alessandro Mineo ◽  
Marc Furriols ◽  
Jordi Casanova

The Torso pathway is an ideal model of receptor tyrosine kinase systems, in particular when addressing questions such as how receptor activity is turned on and, equally important, how it is restricted, how different outcomes can be generated from a single signal, and the extent to which gene regulation by signalling pathways relies on the relief of transcriptional repression. In this regard, we considered it pertinent to single out the fundamental notions learned from the Torso pathway beyond the specificities of this system (Furriols and Casanova 2003 EMBO J. 22 , 1947–1952. ( doi:10.1093/emboj/cdg224 )). Since then, the Torso system has gained relevance and its implications beyond its original involvement in morphogenesis and into many disciplines such as oncogenesis, hormone control and neurobiology are now acknowledged. Thus, we believe that it is timely to highlight additional notions supported by new findings and to draw attention to future prospects. Given the late development of research in the field, we wish to devote this review to the events leading to the activation of the Torso receptor, the main focus of our most recent work.

2019 ◽  
Vol 47 (6) ◽  
pp. 1715-1731 ◽  
Author(s):  
Millie Fox ◽  
Claire Crafter ◽  
Darerca Owen

Activated Cdc42-associated kinase or ACK, is a non-receptor tyrosine kinase and an effector protein for the small G protein Cdc42. A substantial body of evidence has accumulated in the past few years heavily implicating ACK as a driver of oncogenic processes. Concomitantly, more is also being revealed regarding the signalling pathways involving ACK and molecular details of its modes of action. Some details are also available regarding the regulatory mechanisms of this kinase, including activation and regulation of its catalytic activity, however, a full understanding of these aspects remains elusive. This review considers the current knowledge base concerning ACK and summarizes efforts and future prospects to target ACK therapeutically in cancer.


2003 ◽  
Vol 31 (6) ◽  
pp. 1445-1446 ◽  
Author(s):  
X. Li ◽  
L. Wheldon ◽  
J.K. Heath

Sprouty was first identified in Drosophila as a novel antagonist of the fibroblast growth factor signalling pathway. Sprouty proteins comprise a big family, members of which are characterized by a cysteine-rich domain which confers inhibitory activity, whereas differences in the N-terminal region may be responsible for functional divergence. The role of Sprouty in RTK (receptor tyrosine kinase) signalling pathways is still controversial. Sprouty may negatively or positively regulate RTK signalling via differential interaction with different signalling molecules, and hence exert different mechanism of action.


2015 ◽  
Vol 20 (5-6) ◽  
pp. 485-508 ◽  
Author(s):  
Theresa M. LaVallee ◽  
Diego Alvarado ◽  
Andrew J. Garton ◽  
E. Sergio Trombetta ◽  
Richard Gedrich ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document